{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:56:21Z","timestamp":1767981381091,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jmii.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T11:00:17Z","timestamp":1406372417000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug reaction with eosinophilia and systemic symptoms during primary Epstein\u2013Barr virus infection"],"prefix":"10.1016","volume":"48","author":[{"given":"Etsuro","family":"Nanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.06.012_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmii.2014.06.012_bib2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jmii.2014.06.012_bib3","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","article-title":"Drug-induced hypersensitivity syndrome associated with Epstein\u2013Barr virus infection","volume":"148","author":"Descamps","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jmii.2014.06.012_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1525-1470.2009.00891.x","article-title":"Drug-induced hypersensivity syndrome associated with Epstein\u2013Barr virus infection: a pediatric case report","volume":"26","author":"Scagni","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jmii.2014.06.012_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1525-1470.2011.01558.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein\u2013Barr virus infection","volume":"28","author":"Bauer","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jmii.2014.06.012_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-007-0753-4","article-title":"Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein\u2013Barr virus","volume":"27","author":"Komatsuda","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jmii.2014.06.012_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1046\/j.1365-2133.2002.05021.x","article-title":"Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity","volume":"147","author":"Renn","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jmii.2014.06.012_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1442-200X.2008.02603.x","article-title":"Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin","volume":"50","author":"Fujiwaki","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jmii.2014.06.012_bib9","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jmii.2014.06.012_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jmv.21445","article-title":"Regulatory T cell activity in primary and persistent Epstein\u2013Barr virus infection","volume":"81","author":"Wingate","year":"2009","journal-title":"J Med Virol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:18:19Z","timestamp":1761657499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118214001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1684118214001236"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.06.012","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug reaction with eosinophilia and systemic symptoms during primary Epstein\u2013Barr virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}